Matt Eyles, who led AHIP for five years, is leaving the group. His departure sur...
Boston Scientific is scrapping its $230 million plan to buy a majority stake in ...
Annexon's trial of an eye disease drug missed by a mile. The company saw a bull'...
Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clini...
The Biden administration wants to help states control Medicaid prescription drug...
Daniel Cleggett has long been a lightning rod in the addiction recovery communit...
The administration is planning a yearly audit to verify prices drugmakers charge...
The FDA is delaying by one month a decision on the approval of a gene therapy fo...
Medical professionals who care for kids are ecstatic they may soon have tools to...
Research on virtual reality is expanding as the technology grows, but too much o...
Researchers at the Beckman Institute for Advanced Science and Technology used de...
On a sunny springtime stroll through a park, it’s easy to ignore the parts of pl...
A new study published in the peer-reviewed OMICS: A Journal of Integrative Biolo...
UNIVERSITY PARK, Pa. — The quest to develop hydrogen as a clean energy source th...
MIAMI, FLORIDA (Strictly EMBARGOED Until May 25, 2023, at 5 P.M. EDT) – Breast c...
University of Cincinnati Cancer Center researchers will present abstracts at the...
